Literature DB >> 2844061

Long-term consequence of early iron-deficiency on dopaminergic neurotransmission in rats.

D Ben-Shachar1, R Ashkenazi, M B Youdim.   

Abstract

Nutritional iron-deficiency (ID) induced in rats caused a reduction in peripheral as well as central iron metabolism. This effect was markedly greater in the liver than the brain. Although the decrease in the rate of brain non-haem iron was slower than that of serum and liver, significant diminutions of behavioral response to apomorphine (2 mg/kg) and maximum [3H]spiperone binding (Bmax) in caudate nucleus were noted in these animals. These effects of ID can be reserved by iron supplementation in young (21-day-old) and adult (48-day-old) rats. In contrast, if ID is induced in new born (10-day-old) animals, the diminished brain non-haem iron, behavioral response to apomorphine and [3H]-spiperone binding in caudate nucleus will not recover even after 6 weeks of iron supplementation. However, these animals have normal serum iron, haemoglobin and liver iron. These data point to the profound effect early ID can have on the development of dopaminergic neurotransmission, since brain iron concentration increases its maximum in the 4-5 weeks after birth. The implications of the present finding is that the prevalence of ID in children occurs in the first decade of life, when brain iron accumulation reaches values observed in adults. The profound cognitive changes associated with ID in children is thought to be dopamine-dependent and is not always reversible with iron therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2844061     DOI: 10.1016/0736-5748(86)90019-5

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  23 in total

Review 1.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

Review 2.  Iron and mechanisms of emotional behavior.

Authors:  Jonghan Kim; Marianne Wessling-Resnick
Journal:  J Nutr Biochem       Date:  2014-08-02       Impact factor: 6.048

3.  Severe postnatal iron deficiency alters emotional behavior and dopamine levels in the prefrontal cortex of young male rats.

Authors:  Yuan Li; Jonghan Kim; Peter D Buckett; Mark Böhlke; Timothy J Maher; Marianne Wessling-Resnick
Journal:  J Nutr       Date:  2011-10-19       Impact factor: 4.798

Review 4.  Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus.

Authors:  M B H Youdim
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

5.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

Review 6.  Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction.

Authors:  Betsy Lozoff
Journal:  J Nutr       Date:  2011-02-23       Impact factor: 4.798

Review 7.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 8.  Biomarkers of Nutrition for Development (BOND)-Iron Review.

Authors:  Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten
Journal:  J Nutr       Date:  2018-06-01       Impact factor: 4.798

9.  Focusing on symptoms rather than diagnoses in brain dysfunction: conscious and nonconscious expression in impulsiveness and decision-making.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

Review 10.  The role of iron in learning and memory.

Authors:  Stephanie J B Fretham; Erik S Carlson; Michael K Georgieff
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.